Skip to main content
    W

    Warby Parker Inc (WRBY)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $26.23
    -1.21 (-4.41%)

    Market Cap: $3.41B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Warby Parker Inc (WRBY) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Warby Parker (WRBY) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Warby Parker reported EPS of $0.05, above the $0.03 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    52%(11/21)
    Avg Surprise
    -25.49%
    Streak
    1 Q

    Upcoming Estimates

    Reports Feb 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.10
    Range$0.08 - $0.14
    15 analysts
    Revenue Consensus
    $255.68M
    Range$238.24M - $285.08M
    16 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.17
    Range$0.14 - $0.22
    4 analysts
    EPS Revisions
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$0.15+10.3%
    60d ago$0.15+8.8%
    30d ago$0.15+8.8%
    7d ago$0.15+8.8%
    Current$0.17
    Revenue Consensus
    $290.63M
    Range$277.30M - $303.66M
    7 analysts

    Next Report

    WRBY has an expected report date of Feb 24, 2027.

    WRBY Earnings Call

    The latest WRBY earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 21 quarters below that had an estimate, WRBY beat 11, missed 4 and matched 6. Revenue for the quarter ended Sep 30, 2026 was $244.74M, up 10.4% from $221.68M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.05$0.03N/A+66.67%Beat-58.3%90 up, 0 downNov 5, 2026$244.74M
    Jun 30, 2026$0.05$0.05N/A0.00%In line+150.0%102 up, 8 downAug 6, 2026$235.51M
    Mar 31, 2026$0.11$0.11$0.09 - $0.130.00%In line-21.4%101 up, 0 downMay 7, 2026$242.45M
    Dec 31, 2025-$0.04$0.01N/A-500.00%MissN/A91 up, 0 downFeb 26, 2026$211.97M
    Sep 30, 2025$0.12$0.09$0.07 - $0.12+33.33%Beat+100.0%109 up, 1 downNov 6, 2025$221.68M
    Jun 30, 2025$0.02$0.02N/A0.00%In line-75.0%101 up, 0 downAug 7, 2025$214.47M
    Mar 31, 2025$0.14$0.11$0.10 - $0.14+27.27%Beat+27.3%82 up, 3 downMay 8, 2025$223.78M
    Dec 31, 2024-$0.06$0.03$0.01 - $0.06-300.00%MissN/A94 up, 2 downFeb 27, 2025$190.64M
    Sep 30, 2024$0.06$0.05$0.03 - $0.07+20.00%Beat+500.0%71 up, 0 downNov 7, 2024$192.45M
    Jun 30, 2024$0.08$0.05$0.04 - $0.06+60.00%Beat+100.0%70 up, 0 downAug 8, 2024$188.22M
    Mar 31, 2024$0.11$0.07$0.06 - $0.08+57.14%Beat+83.3%70 up, 1 downMay 9, 2024$200.00M
    Dec 31, 2023-$0.01$0.01$0.00 - $0.02-200.00%MissN/A70 up, 0 downFeb 28, 2024$161.85M
    Sep 30, 2023$0.01$0.01$0.00 - $0.020.00%In line0.0%90 up, 0 downNov 8, 2023$169.85M
    Jun 30, 2023$0.04$0.02$0.02 - $0.03+100.00%BeatN/A70 up, 0 downAug 9, 2023$166.09M
    Mar 31, 2023$0.06$0.04$0.03 - $0.06+50.00%BeatN/A72 up, 0 downMay 9, 2023$171.97M
    Dec 31, 2022-$0.18$0.00-$0.01 - $0.01N/AN/AN/A71 up, 0 downFeb 28, 2023$146.49M
    Sep 30, 2022$0.01$0.01$0.00 - $0.020.00%In line-50.0%60 up, 1 downNov 10, 2022$148.78M
    Jun 30, 2022-$0.01-$0.02N/A+50.00%BeatN/AN/A0 up, 1 downAug 11, 2022$149.62M
    Mar 31, 2022-$0.04-$0.04-$0.04 - $0.050.00%In lineN/A70 up, 0 downMay 16, 2022$153.22M
    Dec 31, 2021-$0.08-$0.09-$0.12 - -$0.02+11.11%BeatN/A6N/AMar 17, 2022$132.89M
    Sep 30, 2021$0.02-$0.22-$0.71 - $0.44+109.09%BeatN/A6N/ANov 12, 2021$137.37M
    Jun 30, 2021-$0.11-$0.05N/A-120.00%MissN/AN/AN/ASep 29, 2021$131.56M
    Mar 31, 2021-$0.19N/AN/AN/AN/AN/AN/AN/AJun 30, 2021$138.97M
    Dec 31, 2020-$0.19N/AN/AN/AN/AN/AN/AN/AMar 31, 2021$112.84M
    Mar 31, 2020-$0.10N/AN/AN/AN/AN/AN/AN/AJun 29, 2020$88.39M
    Dec 31, 2019-$0.10N/AN/AN/AN/AN/AN/AN/AMar 30, 2020N/A
    Last 26 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $0.24, up 26.3% from the year before. It was -$0.10 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$0.24+26.3%
    Dec 31, 2024$0.19+90.0%
    Dec 31, 2023$0.10N/A
    Dec 31, 2022-$0.22N/A
    Dec 31, 2021-$0.36N/A
    Dec 31, 2020-$0.28N/A
    Dec 31, 2019-$0.10N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,900 words across 13 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20267,92513
    2026Q2Jun 30, 20268,21411
    2026Q1Mar 31, 20268,14612
    2025Q4Dec 31, 20258,67112
    2025Q3Sep 30, 20257,38312
    2025Q2Jun 30, 20257,16810
    2025Q1Mar 31, 20257,08112
    2024Q4Dec 31, 20248,43211

    2026Q3 Earnings Call

    Opening remarks

    Jaclyn Berkley Head of Investor Relations Thank you, and good morning, everyone. With me today are Neil Harris Blumenthal and David Abraham Gilboa, our cofounders and co-CEOs, alongside Adrian Mitchell, our Chief Financial Officer. Before we begin, we have a couple of reminders. Our earnings release and slide presentation are available on our website at investors.warbyparker.com. During this call and in our presentation, we will be making comments of a forward-looking nature. Actual results may differ materially from those expressed or implied as a result of various risks and uncertainties. For more information about some of these risks, please review the company's SEC filings, including the section titled Risk Factors in the company's latest annual report on Form 10-K. These forward-looking statements are based on information as of November 5, 2026. Except as required by law, we assume no obligation to publicly update or revise our forward-looking statements. Additionally, we will be discussing certain non-GAAP financial measures. These non-GAAP financial measures are in addition to, and not a substitute for, measures of financial performance prepared in accordance with U.S. GAAP. A reconciliation of our non-GAAP measures to the most directly comparable U.S. GAAP measures can be found in this morning's press release and our slide deck available on our IR website. With that, I will pass it over to David to kick us off.

    David Abraham Gilboa Co-CEO Thank you, Jaclyn, and good morning. Throughout 2026, we have made significant investments in our most important long-term growth initiatives while continuing to execute against the core business. In the third quarter, we delivered revenue growth of 10.4% and adjusted EBITDA above our guidance, even as we lapped our strongest revenue growth and highest margin expansion of last year. We delivered this level of profitability while balancing a number of investments and initiatives across the business. We are continuing to focus on opportunities that we believe can drive stronger top-line growth in the years ahead. We are already seeing progress across several of these areas. We have opened 41 net new stores year to date, ahead of last year's pace, further expanding the reach of our brand and holistic eye care offering. E-commerce growth accelerated to 5%, its strongest quarterly growth since we sunset Home Try-On, while eye exams and insurance grew 30% and 22% year over year, respectively. These are areas we have been investing in for years, and we are encouraged by the momentum we are seeing as they become increasingly meaningful contributors to our growth. We are also introducing newness to our assortment, including today's launch of our collaboration with Rare Beauty by Selena Gomez, which enables us to reach new audiences.

    Frequently Asked Questions About WRBY

    When is Warby Parker's next earnings date?

    Warby Parker's next earnings report is expected for Feb 24, 2027.

    Did WRBY beat earnings estimates last quarter?

    Yes. Warby Parker reported EPS of $0.05 for the quarter ended Sep 30, 2026, above the $0.03 estimate, a 66.67% surprise.

    What EPS do analysts expect from WRBY next quarter?

    The consensus EPS estimate for Warby Parker for the quarter ending Dec 31, 2026 is $0.10 from 15 analysts, with estimates from $0.08 to $0.14.

    How often does WRBY beat earnings estimates?

    Warby Parker beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -84.09%.